Trial Profile
Randomized controlled trial of SAVVY [C31G] and HIV in Nigeria
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs C31G (Primary)
- Indications HIV-1 infections; HIV-2 infections
- Focus Therapeutic Use
- 14 Nov 2005 New trial record.